Next Article in Journal / Special Issue
Intraocular Implants for the Treatment of Autoimmune Uveitis
Previous Article in Journal
The Effect of Superstructures Connected to Implants with Different Surface Properties on the Surrounding Bone
Previous Article in Special Issue
Human Keratoconus Cell Contractility is Mediated by Transforming Growth Factor-Beta Isoforms
Open AccessReview

Bioengineered Lacrimal Gland Organ Regeneration in Vivo

1
Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo 160-8582, Japan
2
Laboratory of Organ Regeneration, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan
3
Organ Technologies Inc., Chiyoda-ku, Tokyo 101-0048, Japan
*
Author to whom correspondence should be addressed.
Academic Editor: Dimitrios Karamichos
J. Funct. Biomater. 2015, 6(3), 634-649; https://doi.org/10.3390/jfb6030634
Received: 27 June 2015 / Revised: 18 July 2015 / Accepted: 23 July 2015 / Published: 30 July 2015
(This article belongs to the Special Issue Ocular Tissue Engineering)
The lacrimal gland plays an important role in maintaining a homeostatic environment for healthy ocular surfaces via tear secretion. Dry eye disease, which is caused by lacrimal gland dysfunction, is one of the most prevalent eye disorders and causes ocular discomfort, significant visual disturbances, and a reduced quality of life. Current therapies for dry eye disease, including artificial tear eye drops, are transient and palliative. The lacrimal gland, which consists of acini, ducts, and myoepithelial cells, develops from its organ germ via reciprocal epithelial-mesenchymal interactions during embryogenesis. Lacrimal tissue stem cells have been identified for use in regenerative therapeutic approaches aimed at restoring lacrimal gland functions. Fully functional organ replacement, such as for tooth and hair follicles, has also been developed via a novel three-dimensional stem cell manipulation, designated the Organ Germ Method, as a next-generation regenerative medicine. Recently, we successfully developed fully functional bioengineered lacrimal gland replacements after transplanting a bioengineered organ germ using this method. This study represented a significant advance in potential lacrimal gland organ replacement as a novel regenerative therapy for dry eye disease. In this review, we will summarize recent progress in lacrimal regeneration research and the development of bioengineered lacrimal gland organ replacement therapy. View Full-Text
Keywords: lacrimal glands; regenerative medicine; 3D cell manipulation; organ regeneration; dry eye disease lacrimal glands; regenerative medicine; 3D cell manipulation; organ regeneration; dry eye disease
Show Figures

Figure 1

MDPI and ACS Style

Hirayama, M.; Tsubota, K.; Tsuji, T. Bioengineered Lacrimal Gland Organ Regeneration in Vivo. J. Funct. Biomater. 2015, 6, 634-649.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop